Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
PDUFA VIII Could Boost US FDA Biomarker Qualification Program Resources, Incentives
Feb 10 2026
•
By
Sue Sutter
Obstacles in the biomarker qualification pathway make it difficult to navigate.
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Review Pathways
More from United States